Middlesex
United Kingdom
25
2021-12-23
24
2023-07-11
These are the the leading inventors for applications assigned to GlaxoSmithKline Intellectual Property Development Limited:
GlaxoSmithKline Intellectual Property Development Limited based in Middlesex, GB has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
C-mannoside compounds useful for the treatment of urinary tract infections
#2 | 2021-09-16 β Patent 11,530,238 granted on 2022-12-20Methods for purifying antibodies
#3 | 2021-04-15 β Patent 11,197,857 granted on 2021-12-14Combination therapy
#4 | 2021-01-14 β Patent 11,492,361 granted on 2022-11-08Compounds useful in HIV therapy
#5 | 2020-08-13 β Patent 11,969,423 granted on 2024-04-30Compounds
#6 | 2020-06-04 β Patent 11,253,499 granted on 2022-02-22Compounds
#7 | 2020-05-28 β Patent 11,078,287 granted on 2021-08-03Binding agonist for treatment of neurological and other disorders
#8 | 2020-04-23 β Patent 11,130,811 granted on 2021-09-28ICOS binding proteins
#9 | 2020-04-16 β Patent 10,899,754 granted on 2021-01-26Modulators of indoleamine 2,3-dioxygenase
#10 | 2020-03-12 β Patent 10,975,081 granted on 2021-04-13Substituted fused pyrazole compounds and their use as LRRK2 inhibitors
#11 | 2020-02-27 β Patent 11,117,905 granted on 2021-09-14Bisaryl heterocycles as NRF2 activators
#12 | 2020-02-06 β Patent 11,053,212 granted on 2021-07-06Benzimidazole derivatives as bromodomain inhibitors
#13 | 2019-11-28 β Patent 10,858,367 granted on 2020-12-08Compounds
#14 | 2019-08-29 β Patent 10,940,154 granted on 2021-03-09Heterocyclic amides as kinase inhibitors
#15 | 2019-08-22 β Patent 11,649,289 granted on 2023-05-16Anti-ICOS and anti-PD-1 antibody combination therapy
#16 | 2019-08-08 β Patent 11,053,234 granted on 2021-07-061,3 di-substituted cyclobutane or azetidine derivatives as hematopoietic prostaglandin D synthase inhibitors
#17 | 2019-07-04 β Patent 10,933,070 granted on 2021-03-02Heterocyclic amides as kinase inhibitors
#18 | 2019-06-27 β Patent 10,975,056 granted on 2021-04-13Substituted pyridines as inhibitors of DNMT1
#19 | 2019-06-13 β Patent 11,098,312 granted on 2021-08-24Method of producing a recombinant protein
#20 | 2019-05-02 β Patent 11,119,158 granted on 2021-09-14Wireless mechanism for detecting an open or closed container, and methods of making and using the same
#21 | 2017-07-13 β Patent 9,902,735 granted on 2018-02-27Heteroaryl substituted compounds as RORΞ³ inhibitors
#22 | 2017-04-13 β Patent 9,868,724 granted on 2018-01-16Compounds
#23 | 2014-09-25 β Patent 10,344,088 granted on 2019-07-09Antigen binding proteins
#24 | 2014-07-31 β Patent 9,051,325 granted on 2015-06-09Bicyclic [5,6] imidazo pyrimodone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA
#25 | 2013-11-28METHOD OF ADMINISTRATION AND TREATMENT
Also check out GlaxoSmithKline Intellectual Property Development Limited's (Middlesex, United Kingdom) applicant profile with 50 patent applications submitted.
47068 β